Skip to content
GenoLensGenoLens

PAICS

Chr 4q12

phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase

Aliases:
ADE2H1, AIRC
MANE:
ENST00000512576.3

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • phosphoribosylaminoimidazole carboxylase deficiency

    0.60
  • Polyhydramnios

    0.37
  • acute myeloid leukemia

    0.17
  • neoplasm

    0.11
  • non-small cell lung carcinoma

    0.10
  • breast carcinoma

    0.10
  • breast cancer

    0.10
  • colorectal carcinoma

    0.10
  • central nervous system cancer

    0.08
  • glioma

    0.08

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Bifunctional phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase

Bifunctional phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazole succinocarboxamide synthetase catalyzing two reactions of the de novo purine biosynthetic pathway

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.